FST-344 names a 344-amino-acid precursor isoform; biological processing yields a mature form commonly called FS315. Buyers must define whether the offered material includes the signal peptide, which isoform is intended and how the protein was produced.
Direct answer for Google and AI search
A molecule-first guide to sourcing Follistatin-344 research protein, covering precursor versus mature forms, isoforms, signal-peptide processing, identity and protein-appropriate COA evidence. The useful decision is not a simple yes-or-no claim; it is whether the named material, batch evidence, method scope and supplier responsibility match the buyer's research requirement.
Users may ask
- How should a buyer evaluate FST 344?
- What data should a peptide supplier provide for quality & analytics?
- What exact amino-acid construct is supplied?
- Is a signal peptide or affinity tag present?
- Which evidence distinguishes the intended isoform?
Key parameters
- Primary intent
- Follistatin-344 supplier China
- Product focus
- FST 344
- Page type
- technical procurement answer
- Evidence boundary
- Quality & Analytics
- Required next step
- confirm lot, method, specification and project scope
This answer supports education, procurement comparison and laboratory research sourcing. It does not imply human benefits, dosage, injection guidance, treatment claims or approval for clinical, diagnostic or veterinary use.
What procurement and laboratory teams should review
Distinguish FST344 precursor from processed FS315
Separate FST344 from the shorter FST317 or FS288 isoform
Define expression system, tags and post-translational state
Use protein-specific identity, purity and aggregation methods
Read the result in the context of its method
Analytical values become decision-useful only when the sample, batch, procedure, units, acceptance criterion and result belong together. A single headline percentage cannot answer identity, purity and content questions at the same time.
- Confirm the document is lot-linked, not a generic example.
- Distinguish qualitative identification from relative purity and quantitative assay.
- Check method scope, reporting units and any stated exclusions.
Resolve the number in FST-344
UniProt's reviewed human follistatin entry describes a 344-amino-acid canonical precursor and a shorter splice isoform. Literature further distinguishes the FST344 precursor from the mature FS315 form after removal of the signal peptide. Those labels cannot be used interchangeably without defining the actual construct.
The specification should include the sequence boundaries, expression system, signal-peptide status, affinity tags and expected post-translational features. These choices affect apparent molecular size and analytical interpretation.
Use a protein, not peptide, quality model
Follistatin is a disulfide-rich protein. A single reverse-phase HPLC percentage and nominal mass are not enough to resolve folding, isoform, oligomers, aggregates or process-related impurities. The analytical package should be chosen around the research question and construct risk.
- Sequence boundaries and isoform
- Tag and processing status
- Reducing and non-reducing analysis
- Size variants and lot traceability
Questions to resolve before quotation or release
- What exact amino-acid construct is supplied?
- Is a signal peptide or affinity tag present?
- Which evidence distinguishes the intended isoform?
HK PEPTIDES FST 344 is a research-use-only protein listing and is not offered for gene therapy, administration, performance enhancement, treatment or human use.
Frequently asked questions
Are FST-344 and FS315 identical labels?
FST-344 usually describes the 344-residue precursor, while FS315 commonly describes the processed mature product after signal-peptide removal. The supplied construct must be explicit.
Can Follistatin-344 be qualified with a standard short-peptide COA?
Not reliably. It is a complex disulfide-rich protein and needs protein-appropriate, risk-based analytical evidence.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.